All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Escend Pharmaceuticals Inc., of Menlo Park, Calif., said its lead compound, ES-3000, received orphan drug designation from the FDA to treat chronic myeloid leukemia.